Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Rankning i aktier #2096
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aktiekurs
$142.09
Senast synkroniserad: 2026-10-21
Marknadsvärde
$9.85B
Förändring (1 dag)
-0.39%
Förändring (1 år)
-56.84%
Land
US
Handel Insulet Corp. (PODD)

Kategori

Healthcare
Aktiekurshistorik för Insulet Corp. (PODD)
Högsta slutkurs: $137.02 den 2026-10-01

Lägsta slutkurs: $15.32 den 2007-05-01
Aktiekurshistorik för Insulet Corp. från 2007 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -28.78%
2025 10.94%
2024 29.28%
2023 -31.55%
2022 12.13%
2021 7.15%
2020 41.98%
2019 122.73%
2018 14.06%
2017 87.47%
2016 -0.45%
2015 -18.45%
2014 23.64%
2013 70.93%
2012 17.30%
2011 23.42%
2010 14.55%
2009 83.92%
2008 -70.52%
2007 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.69 -18.50%
DE